By Karlee Weinmann ( May 8, 2014, 11:45 AM EDT) -- Deal-happy drugmaker Valeant Pharmaceuticals International Inc. said Thursday that it would pursue a campaign to reshape the board of Botox maker Allergan Inc., the company it is targeting alongside activist investor Bill Ackman in a $46 billion hostile takeover play....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.